Switch to:
More From Other Websites
Vertex Pharma Is 'Hyped,' H.C. Wainwright Sees 35% Downside Jul 06 2015
Evercore ISI Analyst Gives Highlights From Vertex's Orkambi Call Jul 05 2015
1:46 pm Vertex Pharma confirms FDA approval of its ORKAMBI to treat the underlying cause of cystic... Jul 05 2015
What You May Have Missed In Biotech: Celgene's $1B Bet On Cancer Immunotherapy, And A New CF Drug Jul 03 2015
Vertex’s $259,000 Cystic Fibrosis Drug Gets FDA Approval Jul 02 2015
Business Highlights Jul 02 2015
Stock Pops & Drops: VRTX, HUM, WU & BP Jul 02 2015
ADDING MULTIMEDIA FDA Approves ORKAMBI™ (lumacaftor/ivacaftor) - the First Medicine to Treat the... Jul 02 2015
FDA clears drug for leading form of cystic fibrosis Jul 02 2015
FDA clears drug for leading form of cystic fibrosis Jul 02 2015
ADDING MULTIMEDIA FDA Approves ORKAMBI™ (lumacaftor/ivacaftor) - the First Medicine to Treat the... Jul 02 2015
Vertex's Orkambi Approved For CF, Prices On High Side Jul 02 2015
Vertex Pharmaceuticals: Now That's an Approval! Jul 02 2015
Trending Now: Vertex Pharmaceuticals Jul 02 2015
FDA approves new Vertex drug, stock halted Jul 02 2015
Vertex Pharma's lung disorder therapy wins FDA nod Jul 02 2015
Vertex Shares Leap On FDA Approval For Cystic Fibrosis Combo ORKAMBI Jul 02 2015
VERTEX PHARMACEUTICALS INC / MA Files SEC form 8-K, Other Events Jul 02 2015
Vertex Wins U.S. Approval for Cystic Fibrosis Combo Orkambi Jul 02 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK